Skip to main contentSkip to footer

ORGANISATIONS WE’VE WORKED WITH

Struggling with Market Access?

The Challenge You Face

  • Complex market access and reimbursement pathways across PBS, MBS and Prescribed List
  • Uncertainty around clinical, economic and value evidence requirements
  • Evolving PBAC, MSAC and MDHTAC expectations and increasing scrutiny
Challenge

How Pulse Economics Solves It

  • Faster progression to funding on the PBS, MBS and Prescribed List with fewer avoidable rework cycles
  • Clinical, economic and pricing evidence built to withstand HTA and payer scrutiny
  • Decision-ready market access strategies aligned to PBAC, MSAC and MDHTAC
  • End-to-end submission support from strategy through to acceptance

WE PROVIDE

Evidence Strategy & Generation

Design and support clinical and real-world evidence strategies that directly address HTA, payer and policy requirements.

Market Access & Reimbursement

Guide clients through the complexities of PBS, MBS and Prescribed List pathways, helping products progress efficiently from evidence generation to reimbursement and patient access.

Commercialisation & Growth Strategy

Developing robust commercialisation strategies for startups and established players, supporting growth and effective life cycle management.

Modelling & Data Analytics

Perform robust statistical, financial and economic modelling that withstand HTA and payer scrutiny.

Health Policy

Support government, research organisations and industry in shaping health policy initiatives.

Most Popular Articles

Imagination is more important than knowledge. Knowledge is limited. Imagination encircles the world.